Treating high-risk neuroblastoma in 2022: where are we now?

This recorded session from Solving Kids’ Cancer UK’s 2022 Neuroblastoma Parent Symposium looks at where we are in treating high‑risk neuroblastoma. Led by Dr Daniel Morgenstern, it offers a clear overview of what neuroblastoma is, where it begins, current treatment approaches in Europe and North America, and the direction of ongoing research.